| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Immunology |
Department of Pathology, Cornell University Medical College, New York, New York 10021 [D. J., Y-T. C.]; Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [E. S., A. O. G., M. J. S., L. J. O.]; and Medizinische Klinik, Hämatologie-Onkologie, Krankenhaus Nordwest, 60488 Frankfurt, Germany [D. J., E. J., A. K.]
SEREX (serological analysis of recombinant tumor cDNA expression libraries) has been applied to several different tumor types and has led to the identification of a wide range of tumor antigens. In this study, a breast cancer library and a normal testicular library were analyzed using autologous and allogeneic breast cancer sera. Thirty genes were isolated, including 27 known genes and 3 previously unknown genes. Among the known genes, two cancer-testis (CT) antigens, NY-ESO-1 and SSX2, previously defined by SEREX analysis, were found. In addition, ING1, a candidate breast cancer suppressor gene, was isolated. This ING1 gene product was also recognized by 2 of 14 allogeneic sera from breast cancer patients but not 12 normal adult sera. Comparison of ING1 cDNA from normal and tumor tissues showed no mutation in the index breast cancer case and revealed the presence of at least three different mRNA transcripts with variable transcription initiation sites and exon usage. Tissue-specific expression of these transcripts was found in normal tissues and tumor cell line mRNAs. Furthermore, a novel gene, designated as ING2, sharing 76% nucleotide homology with ING1 was identified in the breast cancer cDNA library. The basis of the immunogenicity of ING1 and the biological role of ING1 and ING2 need further exploration.
This article has been cited by other articles:
|
|
 |
|
  C. Desmetz, C. Bascoul-Mollevi, P. Rochaix, P.-J. Lamy, A. Kramar, P. Rouanet, T. Maudelonde, A. Mange, and J. Solassol Identification of a New Panel of Serum Autoantibodies Associated with the Presence of In situ Carcinoma of the Breast in Younger Women Clin. Cancer Res., July 15, 2009; 15(14): 4733 - 4741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-H. Shen, K. Y.-K. Chan, U.-S. Khoo, H. Y.-S. Ngan, W.-C. Xue, P.-M. Chiu, P. Ip, and A. N.-Y. Cheung Epigenetic and genetic alterations of p33ING1b in ovarian cancer Carcinogenesis, April 1, 2005; 26(4): 855 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Goeman, D. Thormeyer, M. Abad, M. Serrano, O. Schmidt, I. Palmero, and A. Baniahmad Growth Inhibition by the Tumor Suppressor p33ING1 in Immortalized and Primary Cells: Involvement of Two Silencing Domains and Effect of Ras Mol. Cell. Biol., January 1, 2005; 25(1): 422 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H.Y. He, C. C. Helbing, M. J. Wagner, C. W. Sensen, and K. Riabowol Phylogenetic Analysis of the ING Family of PHD Finger Proteins Mol. Biol. Evol., January 1, 2005; 22(1): 104 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Fernandez-Madrid, N. Tang, H. Alansari, J. L. Granda, L. Tait, K. C. Amirikia, M. Moroianu, X. Wang, and R. L. Karvonen Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer Cancer Res., August 1, 2004; 64(15): 5089 - 5096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yan, L. Phan, F. Yang, M. Talpaz, Y. Yang, Z. Xiong, B. Ng, N. A. Timchenko, C. J. Wu, J. Ritz, et al. A Novel Mechanism of Alternative Promoter and Splicing Regulates the Epitope Generation of Tumor Antigen CML66-L J. Immunol., January 1, 2004; 172(1): 651 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kameyama, C.-l. Huang, D. Liu, D. Masuya, T. Nakashima, S. Sumitomo, Y. Takami, M. Kinoshita, and H. Yokomise Reduced ING1b Gene Expression Plays an Important Role in Carcinogenesis of Non-Small Cell Lung Cancer Patients Clin. Cancer Res., October 15, 2003; 9(13): 4926 - 4934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Odunsi, A. A. Jungbluth, E. Stockert, F. Qian, S. Gnjatic, J. Tammela, M. Intengan, A. Beck, B. Keitz, D. Santiago, et al. NY-ESO-1 and LAGE-1 Cancer-Testis Antigens Are Potential Targets for Immunotherapy in Epithelial Ovarian Cancer Cancer Res., September 15, 2003; 63(18): 6076 - 6083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Nolte, S. Niemann, and U. Muller Specific sequence changes in multiple transcript system DYT3 are associated with X-linked dystonia parkinsonism PNAS, September 2, 2003; 100(18): 10347 - 10352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G S Nouman, J J Anderson, J Lunec, and B Angus The role of the tumour suppressor p33ING1b in human neoplasia J. Clin. Pathol., July 1, 2003; 56(7): 491 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G S Nouman, J J Anderson, S Crosier, J Shrimankar, J Lunec, and B Angus Downregulation of nuclear expression of the p33ING1b inhibitor of growth protein in invasive carcinoma of the breast J. Clin. Pathol., July 1, 2003; 56(7): 507 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Wang, Y. Zhang, H. Liu, E. Salati, M. Chiriva-Internati, and S. H. Lim Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies Blood, February 1, 2003; 101(3): 955 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Rubinstein, A. Stortchevoi, M. Boosalis, R. Ashfaq, and T. Guillaume Overexpression of DNA-binding Protein B Gene Product in Breast Cancer as Detected by in Vitro-generated Combinatorial Human Immunoglobulin Libraries Cancer Res., September 1, 2002; 62(17): 4985 - 4991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Vieyra, R. Loewith, M. Scott, P. Bonnefin, F.-M. Boisvert, P. Cheema, S. Pastyryeva, M. Meijer, R. N. Johnston, D. P. Bazett-Jones, et al. Human ING1 Proteins Differentially Regulate Histone Acetylation J. Biol. Chem., August 9, 2002; 277(33): 29832 - 29839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Vieyra, T. Toyama, Y. Hara, D. Boland, R. Johnston, and K. Riabowol ING1 Isoforms Differentially Affect Apoptosis in a Cell Age-dependent Manner Cancer Res., August 1, 2002; 62(15): 4445 - 4452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G S Nouman, J J Anderson, K M Wood, J Lunec, A G Hall, M M Reid, and B Angus Loss of nuclear expression of the p33ING1b inhibitor of growth protein in childhood acute lymphoblastic leukaemia J. Clin. Pathol., August 1, 2002; 55(8): 596 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Scanlan, S. Welt, C. M. Gordon, Y.-T. Chen, A. O. Gure, E. Stockert, A. A. Jungbluth, G. Ritter, D. Jager, E. Jager, et al. Cancer-related Serological Recognition of Human Colon Cancer: Identification of Potential Diagnostic and Immunotherapeutic Targets Cancer Res., July 15, 2002; 62(14): 4041 - 4047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kuzmichev, Y. Zhang, H. Erdjument-Bromage, P. Tempst, and D. Reinberg Role of the Sin3-Histone Deacetylase Complex in Growth Regulation by the Candidate Tumor Suppressor p33ING1 Mol. Cell. Biol., February 1, 2002; 22(3): 835 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Wagner, M. Gogela-Spehar, R. C. Skirrow, R. N. Johnston, K. Riabowol, and C. C. Helbing Expression of Novel ING Variants Is Regulated by Thyroid Hormone in the Xenopus laevis Tadpole J. Biol. Chem., December 7, 2001; 276(50): 47013 - 47020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kiniwa, T. Fujita, M. Akada, K. Ito, T. Shofuda, Y. Suzuki, A. Yamamoto, T. Saida, and Y. Kawakami Tumor Antigens Isolated from a Patient with Vitiligo and T-Cell-infiltrated Melanoma Cancer Res., November 1, 2001; 61(21): 7900 - 7907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ghadersohi and A. K. Sood Prostate Epithelium-derived Ets Transcription Factor mRNA Is Overexpressed in Human Breast Tumors and Is A Candidate Breast Tumor Marker and A Breast Tumor Antigen Clin. Cancer Res., September 1, 2001; 7(9): 2731 - 2738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K-J. Cheung Jr., D. Mitchell, P. Lin, and G. Li The Tumor Suppressor Candidate p33ING1 Mediates Repair of UV-Damaged DNA Cancer Res., July 1, 2001; 61(13): 4974 - 4977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Scott, F.-M. Boisvert, D. Vieyra, R. N. Johnston, D. P. Bazett-Jones, and K. Riabowol UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences Nucleic Acids Res., May 15, 2001; 29(10): 2052 - 2058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jäger, E. Stockert, A. O. Güre, M. J. Scanlan, J. Karbach, E. Jäger, A. Knuth, L. J. Old, and Y.-T. Chen Identification of a Tissue-specific Putative Transcription Factor in Breast Tissue by Serological Screening of a Breast Cancer Library Cancer Res., March 1, 2001; 61(5): 2055 - 2061. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Scott, P. Bonnefin, D. Vieyra, F.-M. Boisvert, D. Young, D. P. Bazett-Jones, and K. Riabowol UV-induced binding of ING1 to PCNA regulates the induction of apoptosis J. Cell Sci., January 10, 2001; 114(19): 3455 - 3462. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
